Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22


Estrogen-induced ovarian development is time-limited during the temperature-dependent sex determination of the American alligator.

Kohno S, Vang D, Ang E, Brunell AM, Lowers RH, Schoenfuss HL.

Gen Comp Endocrinol. 2020 Jan 25;291:113397. doi: 10.1016/j.ygcen.2020.113397. [Epub ahead of print]


Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves.

Guerra-Maupome M, Vang DX, McGill JL.

PLoS One. 2019 Feb 22;14(2):e0212751. doi: 10.1371/journal.pone.0212751. eCollection 2019.


The Psychological Risk of Minimal Risk Activities: A Pre- and Posttest Study Using the Self-Assessment Manikin.

Murdoch M, Partin MR, Vang D, Kehle-Forbes SM.

J Empir Res Hum Res Ethics. 2019 Feb;14(1):15-22. doi: 10.1177/1556264618810302. Epub 2018 Nov 8.


Expanding the role of clinical pharmacists on interdisciplinary primary care teams for chronic pain and opioid management.

Giannitrapani KF, Glassman PA, Vang D, McKelvey JC, Thomas Day R, Dobscha SK, Lorenz KA.

BMC Fam Pract. 2018 Jul 3;19(1):107. doi: 10.1186/s12875-018-0783-9.


Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions.

Floc'h N, Martin MJ, Riess JW, Orme JP, Staniszewska AD, Ménard L, Cuomo ME, O'Neill DJ, Ward RA, Finlay MRV, McKerrecher D, Cheng M, Vang DP, Burich RA, Keck JG, Gandara DR, Mack PC, Cross DAE.

Mol Cancer Ther. 2018 May;17(5):885-896. doi: 10.1158/1535-7163.MCT-17-0758. Epub 2018 Feb 26.


Repurposing ospemifene for potentiating an antigen-specific immune response.

Kao CJ, Wurz GT, Lin YC, Vang DP, Phong B, DeGregorio MW.

Menopause. 2017 Apr;24(4):437-451. doi: 10.1097/GME.0000000000000776.


Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation.

Vincent L, Vang D, Nguyen J, Benson B, Lei J, Gupta K.

Haematologica. 2016 May;101(5):566-77. doi: 10.3324/haematol.2015.136523. Epub 2015 Dec 24.


Small-molecule nociceptin receptor agonist ameliorates mast cell activation and pain in sickle mice.

Vang D, Paul JA, Nguyen J, Tran H, Vincent L, Yasuda D, Zaveri NT, Gupta K.

Haematologica. 2015 Dec;100(12):1517-25. doi: 10.3324/haematol.2015.128736. Epub 2015 Aug 20.


Assessing the Effects of Concurrent versus Sequential Cisplatin/Radiotherapy on Immune Status in Lung Tumor-Bearing C57BL/6 Mice.

Kao CJ, Wurz GT, Lin YC, Vang DP, Griffey SM, Wolf M, DeGregorio MW.

Cancer Immunol Res. 2015 Jul;3(7):741-50. doi: 10.1158/2326-6066.CIR-14-0234. Epub 2015 Feb 11.


Data mining strategies to improve multiplex microbead immunoassay tolerance in a mouse model of infectious diseases.

Mani A, Ravindran R, Mannepalli S, Vang D, Luciw PA, Hogarth M, Khan IH, Krishnan VV.

PLoS One. 2015 Jan 23;10(1):e0116262. doi: 10.1371/journal.pone.0116262. eCollection 2015.


Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene.

Dandapat A, Bosnakovski D, Hartweck LM, Arpke RW, Baltgalvis KA, Vang D, Baik J, Darabi R, Perlingeiro RC, Hamra FK, Gupta K, Lowe DA, Kyba M.

Cell Rep. 2014 Sep 11;8(5):1484-96. doi: 10.1016/j.celrep.2014.07.056. Epub 2014 Aug 28.


Antitumor effects of cisplatin combined with tecemotide immunotherapy in a human MUC1 transgenic lung cancer mouse model.

Kao CJ, Wurz GT, Monjazeb AM, Vang DP, Cadman TB, Griffey SM, Wolf M, DeGregorio MW.

Cancer Immunol Res. 2014 Jun;2(6):581-9. doi: 10.1158/2326-6066.CIR-13-0205. Epub 2014 Mar 10.


Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer.

Nguyen J, Luk K, Vang D, Soto W, Vincent L, Robiner S, Saavedra R, Li Y, Gupta P, Gupta K.

Br J Anaesth. 2014 Jul;113 Suppl 1:i4-13. doi: 10.1093/bja/aeu090. Epub 2014 May 26.


Induction of invasive transitional cell bladder carcinoma in immune intact human MUC1 transgenic mice: a model for immunotherapy development.

Vang DP, Wurz GT, Griffey SM, Kao CJ, Gutierrez AM, Hanson GK, Wolf M, DeGregorio MW.

J Vis Exp. 2013 Oct 30;(80):e50868. doi: 10.3791/50868.


Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer.

Zylla D, Gourley BL, Vang D, Jackson S, Boatman S, Lindgren B, Kuskowski MA, Le C, Gupta K, Gupta P.

Cancer. 2013 Dec 1;119(23):4103-10. doi: 10.1002/cncr.28345. Epub 2013 Sep 16.


Mast cell activation contributes to sickle cell pathobiology and pain in mice.

Vincent L, Vang D, Nguyen J, Gupta M, Luk K, Ericson ME, Simone DA, Gupta K.

Blood. 2013 Sep 12;122(11):1853-62. doi: 10.1182/blood-2013-04-498105. Epub 2013 Jun 17.


Antitumor effects of L-BLP25 antigen-specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model.

Wurz GT, Gutierrez AM, Greenberg BE, Vang DP, Griffey SM, Kao CJ, Wolf M, DeGregorio MW.

J Transl Med. 2013 Mar 13;11:64. doi: 10.1186/1479-5876-11-64.


Morphine promotes renal pathology in sickle mice.

Weber ML, Vang D, Velho PE, Gupta P, Crosson JT, Hebbel RP, Gupta K.

Int J Nephrol Renovasc Dis. 2012;5:109-18. doi: 10.2147/IJNRD.S33813. Epub 2012 Jul 20.


The aging myostatin null phenotype: reduced adiposity, cardiac hypertrophy, enhanced cardiac stress response, and sexual dimorphism.

Jackson MF, Luong D, Vang DD, Garikipati DK, Stanton JB, Nelson OL, Rodgers BD.

J Endocrinol. 2012 Jun;213(3):263-75. doi: 10.1530/JOE-11-0455. Epub 2012 Mar 19.


Influence of morphine on pericyte-endothelial interaction: implications for antiangiogenic therapy.

Luk K, Boatman S, Johnson KN, Dudek OA, Ristau N, Vang D, Nguyen J, Gupta K.

J Oncol. 2012;2012:458385. doi: 10.1155/2012/458385. Epub 2012 Jan 17.


Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness.

Cain DM, Vang D, Simone DA, Hebbel RP, Gupta K.

Br J Haematol. 2012 Feb;156(4):535-44. doi: 10.1111/j.1365-2141.2011.08977.x. Epub 2011 Dec 15.


Neurilemoma of the posterior tibial nerve and tarsal tunnel syndrome.

Miranpuri S, Snook E, Vang D, Yong RM, Chagares WE.

J Am Podiatr Med Assoc. 2007 Mar-Apr;97(2):148-50.


Supplemental Content

Support Center